Reply to thread

I also found this.    You may need to register to see the article.   The vote by the ACIP to approve this as the preference over Zostavax was 8-7, which is I understand was highly unusual with respect to having such a divided committee.    Definitely going to wait and watch. 


https://www.medscape.com/viewarticle/887626



Back
Top